Home » Angiotech Spinning Off Non-Taxus Assets
Angiotech Spinning Off Non-Taxus Assets
Angiotech Pharmaceuticals is packaging its assets not related to the Taxus coronary stent used in cardiac operations into a new subsidiary, Angiotech Pharmaceutical Interventions.
The Canadian Press
The Canadian Press
Upcoming Events
-
07May
-
14May
-
30May